Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Neuromelanins of human brain have soluble and insoluble components with dolichols attached to the melanic structure.

Engelen M, Vanna R, Bellei C, Zucca FA, Wakamatsu K, Monzani E, Ito S, Casella L, Zecca L.

PLoS One. 2012;7(11):e48490. doi: 10.1371/journal.pone.0048490. Epub 2012 Nov 5.

PMID:
23139786
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals.

Zecca L, Bellei C, Costi P, Albertini A, Monzani E, Casella L, Gallorini M, Bergamaschi L, Moscatelli A, Turro NJ, Eisner M, Crippa PR, Ito S, Wakamatsu K, Bush WD, Ward WC, Simon JD, Zucca FA.

Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17567-72. doi: 10.1073/pnas.0808768105. Epub 2008 Nov 6.

PMID:
18988735
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis.

Ferrari E, Engelen M, Monzani E, Sturini M, Girotto S, Bubacco L, Zecca L, Casella L.

J Biol Inorg Chem. 2013 Jan;18(1):81-93. doi: 10.1007/s00775-012-0951-7. Epub 2012 Oct 31.

PMID:
23111628
[PubMed - indexed for MEDLINE]
4.

Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease.

Aime S, Bergamasco B, Casu M, Digilio G, Fasano M, Giraudo S, Lopiano L.

Mov Disord. 2000 Sep;15(5):977-81.

PMID:
11009208
[PubMed - indexed for MEDLINE]
5.

Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.

Brain. 2005 Nov;128(Pt 11):2654-64. Epub 2005 Jul 6.

PMID:
16000336
[PubMed - indexed for MEDLINE]
Free Article
7.

Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.

Double KL, Zecca L, Costi P, Mauer M, Griesinger C, Ito S, Ben-Shachar D, Bringmann G, Fariello RG, Riederer P, Gerlach M.

J Neurochem. 2000 Dec;75(6):2583-9.

PMID:
11080212
[PubMed - indexed for MEDLINE]
8.

The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.

Zecca L, Stroppolo A, Gatti A, Tampellini D, Toscani M, Gallorini M, Giaveri G, Arosio P, Santambrogio P, Fariello RG, Karatekin E, Kleinman MH, Turro N, Hornykiewicz O, Zucca FA.

Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9843-8. Epub 2004 Jun 21.

PMID:
15210960
[PubMed - indexed for MEDLINE]
Free PMC Article
9.
10.

Interaction of neuromelanin and iron in substantia nigra and other areas of human brain.

Zecca L, Shima T, Stroppolo A, Goj C, Battiston GA, Gerbasi R, Sarna T, Swartz HM.

Neuroscience. 1996 Jul;73(2):407-15.

PMID:
8783258
[PubMed - indexed for MEDLINE]
11.

Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.

Sasaki M, Shibata E, Tohyama K, Takahashi J, Otsuka K, Tsuchiya K, Takahashi S, Ehara S, Terayama Y, Sakai A.

Neuroreport. 2006 Jul 31;17(11):1215-8.

PMID:
16837857
[PubMed - indexed for MEDLINE]
12.

Neuromelanins in various regions of human brain are associated with native and oxidized isoprenoid lipids.

Ward WC, Zucca FA, Bellei C, Zecca L, Simon JD.

Arch Biochem Biophys. 2009 Apr 1;484(1):94-9. doi: 10.1016/j.abb.2009.01.013. Epub 2009 Jan 20.

PMID:
19467634
[PubMed - indexed for MEDLINE]
13.

Iron-binding characteristics of neuromelanin of the human substantia nigra.

Double KL, Gerlach M, Sch√ľnemann V, Trautwein AX, Zecca L, Gallorini M, Youdim MB, Riederer P, Ben-Shachar D.

Biochem Pharmacol. 2003 Aug 1;66(3):489-94.

PMID:
12907248
[PubMed - indexed for MEDLINE]
14.

GC/MS analysis of thermally degraded neuromelanin from the human substantia nigra.

Dzierzega-Lecznar A, Kurkiewicz S, Stepien K, Chodurek E, Wilczok T, Arzberger T, Riederer P, Gerlach M.

J Am Soc Mass Spectrom. 2004 Jun;15(6):920-6.

PMID:
15144983
[PubMed - indexed for MEDLINE]
Free Article
15.

Neuromelanins isolated from different regions of the human brain exhibit a common surface photoionization threshold.

Bush WD, Garguilo J, Zucca FA, Bellei C, Nemanich RJ, Edwards GS, Zecca L, Simon JD.

Photochem Photobiol. 2009 Jan-Feb;85(1):387-90. doi: 10.1111/j.1751-1097.2008.00476.x. Epub 2008 Nov 19.

PMID:
19067944
[PubMed - indexed for MEDLINE]
16.

Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.

Fedorow H, Tribl F, Halliday G, Gerlach M, Riederer P, Double KL.

Prog Neurobiol. 2005 Feb;75(2):109-24. Review.

PMID:
15784302
[PubMed - indexed for MEDLINE]
17.

Neuromelanin and Parkinson's disease.

Marsden CD.

J Neural Transm Suppl. 1983;19:121-41.

PMID:
6321645
[PubMed - indexed for MEDLINE]
18.

The structure of neuromelanin and its iron binding site studied by infrared spectroscopy.

Bridelli MG, Tampellini D, Zecca L.

FEBS Lett. 1999 Aug 20;457(1):18-22.

PMID:
10486555
[PubMed - indexed for MEDLINE]
Free Article
19.

Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.

Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y.

Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10.

PMID:
19903734
[PubMed - indexed for MEDLINE]
Free Article
20.

Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.

Hill WD, Arai M, Cohen JA, Trojanowski JQ.

J Comp Neurol. 1993 Mar 15;329(3):328-36.

PMID:
8459049
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk